-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
ADC Therapeutics SA quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q3 2024.
- ADC Therapeutics SA Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $90K.
- ADC Therapeutics SA Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $43.7M.
- ADC Therapeutics SA annual Income Tax Expense (Benefit) for 2023 was $39.1M, a 17127% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)